Julia Perttilä is currently the Director of Medical Affairs/Cardiometabolic Health at Eli Lilly and Company and has over 10 years of experience in the pharmaceutical industry managing medical activities and providing scientific support to stakeholders. They previously served as a Senior Medical Advisor in Cardiovascular & Metabolic at Amgen and as a Medical Advisor for Virology at AbbVie. Julia's extensive research background includes more than 15 years in molecular biology, virology, and biochemistry, with notable projects in diabetes and lipid metabolism. They earned their Master of Science and Doctor of Philosophy degrees in Biosciences, with honors, from Odessa National University and the University of Helsinki, respectively. Julia has a strong publication record and has received significant recognition for their research work, including an Academy of Finland post-doctoral fellowship.
This person is not in any teams
This person is not in any offices